1-5 of 5
Jeong Eun Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venadaparib Is a Novel and Selective PARP Inhibitor with Improved Physicochemical Properties, Efficacy, and Safety

Myongjae Lee, In-Gyu Je, Jeong Eun Kim, Yeongran Yoo, Jong-Ha Lim, Eunhye Jang, Yoonsuk Lee, Dong Keun Song, An-Na Moon, Jeong-Ah Kim, Jinah Jeong, Joon-Tae Park, Jung Woo Lee, Ji-Hoon Yang, Chang-Hee Hong, Sun-Young Park, Young-Whan Park, Nam Seok Baek, Sungsook Lee, Kyoung Soo Ha, SungKu Choi, Won Sik Lee
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (3): 333–342.
DOI: https://doi.org/10.1158/1535-7163.MCT-22-0068
Published: 02 March 2023
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract C057: A phase I study to access the safety and efficacy of valecobulin (CKD-516), oral vascular disruption agent, in combination with irinotecan in patients with previously treated metastatic colorectal cancer

Tae Won Kim, Jeong Eun Kim, Hyeong-Seok Lim, Young Suk Park, Won Ki Kang, Sang Joon Shin, Joong Bae Ahn, Sae-Won Han, Tae-You Kim
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): C057.
DOI: https://doi.org/10.1158/1535-7163.TARG-19-C057
Published: 01 December 2019
View article
Journal Articles

Targeting FGFR Pathway in Human Hepatocellular Carcinoma: Expressing pFGFR and pMET for Antitumor Activity

Jae-Cheol Jo, Eun Kyoung Choi, Jae-Sik Shin, Jai-Hee Moon, Seung-Woo Hong, Ha-Reum Lee, Seung-Mi Kim, Soo-A Jung, Dae-Hee Lee, Seang Hwan Jung, Sun-Hye Lee, Jeong Eun Kim, Kyu-pyo Kim, Yong Sang Hong, Young-Ah Suh, Se Jin Jang, Eun Kyung Choi, Jung Shin Lee, Dong-Hoon Jin, Tae Won Kim
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (11): 2613–2622.
DOI: https://doi.org/10.1158/1535-7163.MCT-14-0780
Published: 03 November 2015
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract A77: Randomized phase II study comparing paclitaxel/carboplatin intercalated with gefitinib to paclitaxel/carboplatin alone for chemotherapy-naive non-small cell lung cancer patients either with history of smoking or with wild-type EGFR.

Dae Ho Lee, Jeong Eun Kim, Yoon J. Choi, Chang Min Choi, Jung-Shin Lee, Sang-We Kim
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A77.
DOI: https://doi.org/10.1158/1535-7163.TARG-13-A77
Published: 01 November 2013
View article
Journal Articles

Abstract A63: NVP-BEZ235, a dual PI3K/mTOR inhibitor, elicits an alternate route for induction of cell death in PTEN null prostate cancer cells.

Jeong Eun Kim, Seoung-Woo Hong, Jae-Sik Shin, Jai-Hee Moon, Ye-Seul Kim, Kyu-pyo Kim, Yong Sang Hong, Jae-Lyun Lee, Dong-Hoon Jin, Tae Won Kim
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A63.
DOI: https://doi.org/10.1158/1535-7163.TARG-13-A63
Published: 01 November 2013
View article